Company Analysis
Sign in

Telomir Pharmaceuticals, Inc. (TELO)

Nasdaq: TELO · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 2023
Full chart Alerts Compare
Grade4.5
◀ Past 5.2● Present 3.6▶ Future 5.0
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Report filedMar 17, 2026Feb 4, 2025Mar 29, 2024·
Research and development2,435,5692,235,3411,574,306833,206
General and administrative8,103,2809,636,333600,19220,941
Total operating expenses10,538,84912,242,1743,942,048854,147
Interest expense·4,338,5421,643,049·
Interest and investment income125,64448,000··
Net income-10,413,205-16,532,716-13,071,864-854,147
Earnings per share, basic-0.33-0.56r0.48r-0.03
Earnings per share, diluted-0.33-0.56r0.48r-0.03
Weighted average shares, basic31,653,09429,539,21927,304,72426,829,284
Weighted average shares, diluted31,653,09429,539,21927,304,724r26,829,284
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton TELO · research, not advice